S1P receptor modulators for treating multiple sclerosis
作者： Christian Schnell , Peter C. Hiestand
DOI:
关键词:
摘要: The present invention relates uses of an S1 P receptor modulator such as 2-substituted 2- amino- propane-1,3-diol or 2-amino-propanol derivatives, e. g. a compound comprising group formula (X) for the treatment prevention neo-angiogenesis associated with demyelinating disease, e.g. multiple sclerosis.
lens.org 参考文章(43)
Paul William Manley, Guido Bold, Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase ,(2001)
Hirofumi Matsuyuki, Kunio Sugahara, Yasuhiro Maeda, Kenji Chiba, Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus. Cellular & Molecular Immunology. ,vol. 3, pp. 11- 19 ,(2006)
Core Journal, FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value Core Evidence. ,vol. 1, pp. 157- 167 ,(2006) , 10.2147/CE.S7448
Hanns J. Bueschelberger, Claus Voelker, Hans G. Mueller, Felix Ruh, Anja Weiner Ringwald née Weiner, Fiber optic coil for a fiber optic measuring system and method for producing the same ,(2001)
Klaus Hinterding, Yuan Mi, Nathanael S. Gray, Lawrence Blas Perez, Peter Ettmayer, Shifeng Pan, Federic Zecri, Wei Wang, Peter Nussbaumer, Kenneth Richad la Montagne, Wenqui Gao, Fan Yi, Sophie Lefebvre, Bis-aromatic alkanols ,(2003)
Jesse M Cedarbaum, Use of vegf inhibitors for the treatment of human cancer ,(2005)
Kenji Yoshitomi Pharmaceutical Ltd. Chiba, Koji Yoshitomi Pharmaceutical Ind. Ltd. Teshima, Tetsuro Fujita, Tadashi Yoshitomi Pharmaceutical Ltd. Mishina, Toshiyuki Yoshitomi Pharmaceutical Ind.Ltd. Kohara, Masatoshi Yoshitomi Pharmaceutical Ind.Ltd. Kiuchi, Kunitomo Yoshitomi Pharmaceutical Ind Ltd. Adachi, Benzene compound and medicinal use thereof ,(1995)
Paul William Manley, Guido Bold, 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors ,(2001)
Paul William Glue, Peter C. Hiestand, Carolyn Ann Foster, Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders ,(2003)
Jürgen Mestan, Paul William Manley, Guido Bold, Pascal Furet, Jose Brüggen, Jeanette Marjorie Wood, Stefano Ferrari, Karl-Heinz Thierauch, Andreas Menrad, Martin Krüger, Dieter Seidelmann, Eckhard Ottow, Andreas Huth, Michael Schirner, Antrhranilic acid amides and the use thereof as medicaments ,(1999)